Zhejiang Shapuaisi Pharmaceutical Co.,Ltd.’s Net Profit Rose 105.3% in First Half of 2023

Zhejiang Shapuaisi Pharmaceutical Co.,Ltd. (浙江莎普爱思药业股份有限公司) (603168.SH) reported a net profit of 73.1 million yuan in the first half of 2023, up 105.3% year-on-year.

Meanwhile, the company posted 341.6 million yuan in revenue, up 21.9% year-on-year.

At the end of the reporting period, it had 2 billion yuan in total assets and 264.6 million yuan in total liabilities, with a liability-to-asset ratio of 13%.